Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 3.12% is 56% below its 5-year average of 7.01%, near the low end of its 5-year range (3.12%–12.56%).
As of the fiscal period ended Wednesday, December 31, 2025. 4.15% below its 12-month average of 3.25%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
3.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
3.25%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
5.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
7.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
7.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
7.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
7.94%
CURRENT VS TTM AVG
-4.15%
CURRENT VS 3Y AVG
-41.85%
CURRENT VS 5Y AVG
-55.51%
CURRENT VS 10Y AVG
-57.39%
CURRENT VS 15Y AVG
-59.94%
CURRENT VS 20Y AVG
-60.71%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-63.42%
vs the sector median at left
Humana Inc.
Market Cap
$44.21B
Return on Invested Capital (ROIC)
3.12%
TTM Avg
3.25%
3Y Avg
5.37%
5Y Avg
7.01%
Market Cap
$43.77B
Return on Invested Capital (ROIC)
40.27%
TTM Avg
37.07%
3Y Avg
34.89%
5Y Avg
35.94%
Market Cap
$49.42B
Return on Invested Capital (ROIC)
11.40%
TTM Avg
11.07%
3Y Avg
14.43%
5Y Avg
15.83%
Market Cap
$38.94B
Return on Invested Capital (ROIC)
12.57%
TTM Avg
12.57%
3Y Avg
13.57%
5Y Avg
12.73%
Market Cap
$38.49B
Return on Invested Capital (ROIC)
8.23%
TTM Avg
8.41%
3Y Avg
8.23%
5Y Avg
6.99%
Market Cap
$53.57B
Return on Invested Capital (ROIC)
11.37%
TTM Avg
10.09%
3Y Avg
4.86%
5Y Avg
-0.22%
Market Cap
$32.78B
Return on Invested Capital (ROIC)
5.69%
TTM Avg
6.03%
3Y Avg
3.95%
5Y Avg
3.95%
Market Cap
$32.19B
Return on Invested Capital (ROIC)
21.54%
TTM Avg
21.87%
3Y Avg
20.30%
5Y Avg
19.27%
Market Cap
$31.83B
Return on Invested Capital (ROIC)
16.61%
TTM Avg
13.40%
3Y Avg
11.07%
5Y Avg
9.62%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Humana Inc. (HUM) | $44.21B | 3.12% | 3.25% | 5.37% | 7.01% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $43.77B | 40.27% | 37.07% | 34.89% | 35.94% |
| Edwards Lifesciences Corporation (EW)vs › | $49.42B | 11.40% | 11.07% | 14.43% | 15.83% |
| Agilent Technologies, Inc. (A)vs › | $38.94B | 12.57% | 12.57% | 13.57% | 12.73% |
| IQVIA Holdings Inc. (IQV)vs › | $38.49B | 8.23% | 8.41% | 8.23% | 6.99% |
| Cardinal Health, Inc. (CAH)vs › | $53.57B | 11.37% | 10.09% | 4.86% | -0.22% |
| Medline Inc. (MDLN)vs › | $32.78B | 5.69% | 6.03% | 3.95% | 3.95% |
| Zoetis Inc. (ZTS)vs › | $32.19B | 21.54% | 21.87% | 20.30% | 19.27% |
| DexCom, Inc. (DXCM)vs › | $31.83B | 16.61% | 13.40% | 11.07% | 9.62% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.63B | 8.84% | 8.56% | 8.37% | 9.38% |
ROIC
3.1%
ROE
6.7%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 3.12% |
| 2024-12-31 | 3.39% |
| 2023-12-31 | 6.79% |
| 2022-12-31 | 8.16% |
| 2021-12-31 | 8.06% |
| 2020-12-31 | 12.56% |
| 2019-12-31 | 11.74% |
| 2018-12-31 | 8.20% |
| 2017-12-31 | 9.02% |
| 2016-12-31 | 3.28% |
| 2015-12-31 | 6.23% |
| 2014-12-31 | 6.71% |
| 2013-12-31 | 7.92% |
| 2012-12-31 | 8.50% |
| 2011-12-31 | 10.71% |
| 2010-12-31 | 10.21% |
| 2009-12-31 | 10.36% |
| 2008-12-31 | 7.99% |
| 2007-12-31 | 8.82% |
| 2006-12-31 | 7.05% |
| 2005-12-31 | 25.38% |
| 2004-12-31 | 7.89% |
| 2003-12-31 | -10.94% |
| 2002-12-31 | -6.72% |
| 2001-12-31 | -6.19% |
| 2000-12-31 | -4.70% |
| 1999-12-31 | -42.44% |
| 1998-12-31 | 26.67% |
| 1997-12-31 | 0.00% |
| 1996-12-31 | 0.00% |
